• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五个欧洲国家中存在运动波动和异动症的帕金森病患者的生活质量

Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.

作者信息

Hechtner Marlene C, Vogt Thomas, Zöllner York, Schröder Sabrina, Sauer Julia B, Binder Harald, Singer Susanne, Mikolajczyk Rafael

机构信息

Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Centre, Johannes Gutenberg University Mainz, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

Department of Neurology, University Medical Centre, Johannes Gutenberg University Mainz, Germany.

出版信息

Parkinsonism Relat Disord. 2014 Sep;20(9):969-74. doi: 10.1016/j.parkreldis.2014.06.001. Epub 2014 Jun 10.

DOI:10.1016/j.parkreldis.2014.06.001
PMID:24953743
Abstract

BACKGROUND

Little is known about the relationship between specific subtypes of treatment-associated motor complications and different domains of health-related Quality of Life (QoL) in patients with Parkinson's disease (PD). Larger studies that investigate these aspects within a cross-cultural setting are scarce.

OBJECTIVE

To assess QoL and its association with on-off fluctuations, peak-dose dyskinesias, biphasic dyskinesias, and off-dystonias in PD patients from five European countries.

METHODS

Data from 817 PD patients were collected cross-sectionally in France, Germany, Italy, Spain, and the UK. QoL was measured with the generic EuroQoL 5-Dimension questionnaire (EQ-5D) and the disease-specific Parkinson's Disease Questionnaire-39 (PDQ-39). Multivariable linear regression analyses were performed to test the associations of motor complication subtypes with QoL.

RESULTS

Thirty-three percent of the patients (varying from 23% in Italy to 58% in France) suffered from motor complications, either a single subtype or a combination of different subtypes. On-off fluctuations were associated with a 7.1 percentage point decrease in the EQ-5D (p < 0.001) and a 3.6 percentage point deterioration in the PDQ-39 (p = 0.01). Dyskinesias were not seen to affect global QoL scores, but had detrimental effects on the PDQ-39 dimensions activities of daily living, cognitions, stigma, and bodily discomfort. Patients from Spain, Italy, and France had lower global QoL scores in the multivariable analyses than patients from Germany and the UK.

CONCLUSION

Motor complications, primarily on-off fluctuations, may impact QoL in PD patients. This substantiates the importance of clinical strategies targeting the prevention, delay of onset, and management of motor complications in PD patients.

摘要

背景

关于帕金森病(PD)患者中治疗相关运动并发症的特定亚型与健康相关生活质量(QoL)不同领域之间的关系,人们了解甚少。在跨文化背景下研究这些方面的大型研究很少。

目的

评估来自五个欧洲国家的PD患者的生活质量及其与开关波动、峰剂量异动症、双相异动症和关期肌张力障碍的关联。

方法

在法国、德国、意大利、西班牙和英国对817名PD患者进行了横断面数据收集。使用通用的欧洲五维健康量表问卷(EQ-5D)和特定疾病的帕金森病问卷-39(PDQ-39)测量生活质量。进行多变量线性回归分析以测试运动并发症亚型与生活质量的关联。

结果

33%的患者(从意大利的23%到法国的58%不等)患有运动并发症,要么是单一亚型,要么是不同亚型的组合。开关波动与EQ-5D降低7.1个百分点相关(p<0.001),与PDQ-39恶化3.6个百分点相关(p = 0.01)。异动症未被发现影响总体生活质量评分,但对PDQ-39的日常生活活动、认知、耻辱感和身体不适等维度有不利影响。在多变量分析中,来自西班牙、意大利和法国的患者总体生活质量评分低于来自德国和英国的患者。

结论

运动并发症,主要是开关波动,可能会影响PD患者的生活质量。这证实了针对PD患者运动并发症的预防、延迟发作和管理的临床策略的重要性。

相似文献

1
Quality of life in Parkinson's disease patients with motor fluctuations and dyskinesias in five European countries.五个欧洲国家中存在运动波动和异动症的帕金森病患者的生活质量
Parkinsonism Relat Disord. 2014 Sep;20(9):969-74. doi: 10.1016/j.parkreldis.2014.06.001. Epub 2014 Jun 10.
2
Effects of dyskinesias in Parkinson's disease on quality of life and health-related costs: a prospective European study.帕金森病异动症对生活质量和健康相关费用的影响:一项欧洲前瞻性研究。
Eur J Neurol. 2005 Dec;12(12):956-63. doi: 10.1111/j.1468-1331.2005.01096.x.
3
Quality of life in early Parkinson's disease: impact of dyskinesias and motor fluctuations.早期帕金森病的生活质量:异动症和运动波动的影响。
Mov Disord. 2004 Jan;19(1):22-8. doi: 10.1002/mds.10642.
4
Impact of the motor complications of Parkinson's disease on the quality of life.帕金森病运动并发症对生活质量的影响。
Mov Disord. 2005 Feb;20(2):224-30. doi: 10.1002/mds.20279.
5
Efficacy of combining levodopa with entacapone on quality of life and activities of daily living in patients experiencing wearing-off type fluctuations.左旋多巴与恩他卡朋联合使用对出现剂末现象波动的患者生活质量和日常生活活动的疗效。
Acta Neurol Scand. 2005 Jan;111(1):21-8. doi: 10.1111/j.1600-0404.2004.00363.x.
6
High-dose treatment with pergolide in Parkinson's disease patients with motor fluctuations and dyskinesias.用培高利特高剂量治疗帕金森病伴运动波动和异动症患者。
Parkinsonism Relat Disord. 2005 Sep;11(6):393-8. doi: 10.1016/j.parkreldis.2005.03.005.
7
Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.帕金森病非运动症状对健康相关和感知生活质量的影响。
J Neurol Sci. 2013 Sep 15;332(1-2):136-40. doi: 10.1016/j.jns.2013.07.005. Epub 2013 Jul 25.
8
Neurostimulation for Parkinson's disease with early motor complications.神经刺激治疗帕金森病伴早期运动并发症。
N Engl J Med. 2013 Feb 14;368(7):610-22. doi: 10.1056/NEJMoa1205158.
9
Risk and course of motor complications in a population-based incident Parkinson's disease cohort.基于人群的帕金森病发病队列中运动并发症的风险及病程
Parkinsonism Relat Disord. 2016 Jan;22:48-53. doi: 10.1016/j.parkreldis.2015.11.007. Epub 2015 Nov 6.
10
Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.左旋多巴对晚期帕金森病的疗效和运动功能的影响。
J Parkinsons Dis. 2018;8(1):59-70. doi: 10.3233/JPD-171181.

引用本文的文献

1
Dopaminergic signalling in gastrointestinal health and disease.胃肠道健康与疾病中的多巴胺能信号传导
Nat Rev Gastroenterol Hepatol. 2025 Sep 8. doi: 10.1038/s41575-025-01112-5.
2
Use of safinamide for treatment of Parkinson disease: real-world data from Spain.沙芬酰胺用于治疗帕金森病:来自西班牙的真实世界数据。
Drugs Context. 2025 Jul 25;14. doi: 10.7573/dic.2025-5-5. eCollection 2025.
3
Vital nutrition: enhancing health in advanced Parkinson's disease with device-aided therapies.重要营养:通过设备辅助疗法改善晚期帕金森病患者的健康状况
J Neural Transm (Vienna). 2025 Apr 24. doi: 10.1007/s00702-025-02935-x.
4
The association between non-motor symptoms and cost in Parkinson's disease.帕金森病中非运动症状与成本之间的关联。
J Neurol. 2025 Mar 28;272(4):297. doi: 10.1007/s00415-025-13044-w.
5
Invasive therapies for Parkinson's disease: an adapted excerpt from the guidelines of the German Society of Neurology.帕金森病的侵入性治疗:德国神经病学学会指南的改编摘录
J Neurol. 2025 Feb 22;272(3):219. doi: 10.1007/s00415-025-12915-6.
6
Long-Term Real-World Experience with Safinamide in Patients with Parkinson's Disease.沙芬酰胺治疗帕金森病患者的长期真实世界经验
Brain Sci. 2024 Dec 9;14(12):1238. doi: 10.3390/brainsci14121238.
7
Evaluation of motor fluctuations in Parkinson's disease: electronic vs. conventional paper diaries.帕金森病运动波动的评估:电子日记与传统纸质日记
Front Neurol. 2024 Nov 22;15:1476708. doi: 10.3389/fneur.2024.1476708. eCollection 2024.
8
The Effect of Dysautonomia on Motor, Behavioral, and Cognitive Fluctuations in Parkinson's Disease.自主神经功能障碍对帕金森病运动、行为和认知波动的影响。
Mov Disord. 2025 Jan;40(1):157-162. doi: 10.1002/mds.30044. Epub 2024 Oct 25.
9
Assessments scales for the evaluation of health-related quality of life in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy: a systematic review.帕金森病、进行性核上性麻痹和多系统萎缩中与健康相关生活质量评估量表的系统评价
Front Psychol. 2024 Sep 10;15:1438830. doi: 10.3389/fpsyg.2024.1438830. eCollection 2024.
10
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.左旋多巴诱导的运动障碍在帕金森病中很常见,且影响生活质量:一项为期 5 年的随访研究。
Mov Disord Clin Pract. 2024 Jul;11(7):830-849. doi: 10.1002/mdc3.14056. Epub 2024 May 15.